It is well established that serum CA125 levels can be elevated in patients with ovarian cancer, but this biomarker has a low sensitivity in the early stages of disease and raised CA125 levels have also been observed in other physiological or pathological conditions, including menstruation, pregnancy, endometriosis and inflammatory diseases of the peritoneum [17]. Here, MUC16 is linked to endometriosis.